1. Clinical Overview
Benfotiamine is a lipid-soluble, synthetic S-acyl derivative of thiamine (vitamin B1). It is a prodrug with significantly higher bioavailability than water-soluble thiamine salts. Primarily used in India for the management of diabetic neuropathy and other conditions associated with thiamine deficiency or increased metabolic demand. It acts by increasing transketolase activity, reducing advanced glycation end products (AGEs), and mitigating oxidative stress and inflammation, particularly in neuronal tissues.
| Onset | Duration | Bioavailability |
|---|---|---|
| Clinical symptom improvement in diabetic neuropathy may be observed within 4-8 weeks of continuous therapy. Peak plasma concentrations are reached approximately 1.2-1.5 hours after oral administration. | The pharmacological effects are sustained with once or twice daily dosing due to its high tissue distribution and prolonged intracellular retention of thiamine diphosphate (the active coenzyme). | Approximately 3.6 times higher bioavailability compared to water-soluble thiamine salts. Oral bioavailability of benfotiamine is roughly 5-10%, but it results in significantly higher tissue levels of thiamine diphosphate due to superior cellular uptake. |
2. Mechanism of Action
Benfotiamine increases intracellular levels of thiamine diphosphate (TDP), a critical coenzyme for transketolase, a key enzyme in the pentose phosphate pathway. This activation of transketolase redirects excess triose phosphates (like fructose-6-phosphate and glyceraldehyde-3-phosphate) away from three major pathways of hyperglycemic damage: 1) The Advanced Glycation End-product (AGE) pathway, 2) The Protein Kinase C (PKC) pathway, and 3) The Hexosamine pathway. By inhibiting these pathways, it reduces oxidative stress, inflammation, and endothelial dysfunction, particularly in nerves and blood vessels.
3. Indications & Uses
- Diabetic Peripheral Neuropathy (symptomatic management of pain, paresthesia, burning sensation)
- Thiamine Deficiency States (including Wernicke-Korsakoff syndrome, beriberi - though parenteral thiamine is preferred for acute deficiency)
- Alcoholic Polyneuropathy (adjunctive management)
4. Dosage & Administration
Adult Dosage: 300-600 mg per day, administered in divided doses (e.g., 100 mg three times daily or 150 mg twice daily). For diabetic neuropathy, a common regimen is 300 mg once daily or in divided doses. The 100mg strength allows for flexible dosing.
Administration: Administer orally with or without food. Taking with food may reduce any potential gastrointestinal discomfort. Tablet should be swallowed whole with a glass of water. Consistent daily intake is important for clinical benefit.
5. Side Effects
Common side effects may include:
- Gastrointestinal discomfort (nausea, epigastric pain)
- Headache
- Skin reactions (rash, pruritus) - rare
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Loop Diuretics (e.g., Furosemide) | May increase renal excretion of thiamine, potentially reducing efficacy. Monitor effect. | Moderate |
| Phenytoin, Barbiturates | Long-term use may reduce thiamine levels. Benfotiamine may help counteract this depletion. | Moderate |
| Fluorouracil (5-FU) Chemotherapy | 5-FU may inhibit the phosphorylation of thiamine to its active form (TDP). Significance with benfotiamine is unclear. | Minor |
| Alcohol (Chronic use) | Causes thiamine deficiency. Benfotiamine is used to treat this, but abstinence is primary therapy. | Moderate |
7. Patient Counselling
- DO take the medication regularly as prescribed for optimal effect in neuropathy.
- DO continue your prescribed diet, exercise, and anti-diabetic medications (if diabetic).
- DO inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- DONT stop the medication abruptly if you feel better; consult your doctor.
- DONT use benfotiamine as a substitute for a balanced diet.
8. Toxicology & Storage
Overdose: No reports of acute toxicity or lethal overdose with benfotiamine. Thiamine is water-soluble and excess is excreted. Symptoms would likely be an extension of side effects: nausea, agitation, sweating.
Storage: Store below 30°C, in a cool, dry place. Protect from light and moisture. Keep out of reach of children. Do not use after the expiry date printed on the pack.